These alterations impair antigen presentation and cytotoxic T-cell infiltration, creating a protumorigenic niche that facilitates immune evasion and may contribute to reduced responsiveness to PD-1 blockade in ulcer-related cSCC [19,49,53,54,55]. This evidence concerns the gene RPL17 and skin squamous cell carcinoma.